{"nctId":"NCT02104895","briefTitle":"Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy Versus Whole Breast Irradiation","startDateStruct":{"date":"2005-03"},"conditions":["Breast Cancer"],"count":520,"armGroups":[{"label":"Whole breast irradiation (WBI)","type":"ACTIVE_COMPARATOR","interventionNames":["Radiation: Whole breast irradiation (WBI)"]},{"label":"Partial breast irradiation (APBI)","type":"EXPERIMENTAL","interventionNames":["Radiation: Accelerated partial breast irradiation (APBI)"]}],"interventions":[{"name":"Accelerated partial breast irradiation (APBI)","otherNames":[]},{"name":"Whole breast irradiation (WBI)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age at presentation \\>40 y\n* Tumor size \\<25 mm\n* Wide excision or quadrantectomy with clear margins (\\>5 mm)\n* Clips placed in tumor bed\n* Full informed consent from patient\n\nExclusion Criteria:\n\n* Cardiac dysfunction\n* Forced expiratory volume in 1 second (FEV1) \\<1 L/m\n* Extensive intraductal carcinoma\n* Multifocal cancer\n* Psychiatric problems\n* Recurrent breast cancer","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"40 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Ipsilateral Breast Tumor Recurrence","description":"We defined local relapse (true recurrence) as the reappearance of the breast cancer in the index quadrant and ipsilateral breast tumours as any new breast cancer diagnosed in other quadrants of the same breast. The sum of local relapses and new ipsilateral breast tumours was defined as the ipsilateral breast tumour recurrence (IBTR). Locoregional tumour recurrence also included any recurrence in the ipsilateral axillary, supraclavicular, or internal mammary chain nodal regions.here we report the percentage of participants in each arm who experienced \"Ipsilateral Breast Tumor Recurrence\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":null},{"groupId":"OG001","value":"1.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Acute Skin Toxicity","description":"Acute skin toxicity ≥ grade 2, here we report the percentage of participants in each arm who experienced \"Acute skin toxicity ≥ grade 2","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37.7","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Excellent Cosmesis","description":"Physician-rated cosmesis, Cosmetic outcome was scored on the four-category Harvard Breast Cosmesis Scale. An excellent cosmetic result score was assigned when the treated breast looked like the contralateral one; a good cosmetic score was assigned for minimal but identifiable radiation effects of the treated breast; a fair score was used if significant radiation effects were readily observable; a poor score was used for severe sequelae due to radiation effects","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"89.6","spread":null},{"groupId":"OG001","value":"95.1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":260},"commonTop":["acute skin toxicity, any grade","late skin toxicity, any grade"]}}}